# Prazosin for Smoking Cessation

> **NCT01642433** · PHASE2 · TERMINATED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 1 (actual)

## Conditions studied

- Nicotine Dependence

## Interventions

- **DRUG:** Placebo
- **DRUG:** Prazosin

## Key facts

- **NCT ID:** NCT01642433
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2015-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01642433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01642433, "Prazosin for Smoking Cessation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01642433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*